| Human Molecular Genetics | Pages |
Association of ulcerative colitis with rare VNTR alleles of the human intestinal mucin gene, MUC3
Introduction
Results
Discussion
Materials And Methods
Patients and controls
Reverse transcription and PCR amplification (RT-PCR)
Southern blotting analysis
Statistical analysis
References
Association of ulcerative colitis with rare VNTR alleles of the human intestinal mucin gene, MUC3
INTRODUCTION
Ulcerative colitis (UC) is one of the most common forms of inflammatory bowel diseases (IBDs), a condition with a prevalence of 50-150 per 100 000 population in the Western world (1). Although the aetiology is unknown, epidemiological studies showing familial aggregation of IBD patients (2,3) and increased concordance rates in monozygotic twins compared with dizygotic twins (4,5) have suggested that genetic components are significant. In fact, linkage analysis for susceptibility genes in IBDs involving 186 affected sibling pairs showed evidence for linkage to markers D12S83, D7S669 and D3S1573 with lod scores of 5.47, 3.08 and 2.69, respectively (6). Our investigation was motivated by the fact that marker D7S669 is located near the human intestinal mucin gene MUC3 and by previous reports indicating a possible abnormality in mucin composition in UC patients (7-10).
MUC3 is expressed mainly in the small and large intestines (11,12). This gene contains two separate regions of 51 bp tandem repeats which cover several kilobases and encode portions of the protein backbone, and these regions contain 18 bp interrupting sequences in some of the repeat units (11). Though sequences of the C-terminus and other variable number of tandem repeats (VNTRs) of this gene were elucidated recently (13,14), the entire structure of this gene is still unknown because it is difficult to clone.
Because several diseases are known to be related to VNTR polymorphisms, we looked for an association between the risk of UC and variations in the size of the alleles determined by the 51 bp repetitive element, using both Japanese and Caucasian DNA samples. Here we report the possible involvement of rare MUC3 variants in the development of UC.
RESULTS
We investigated the distribution of sizes of MUC3 alleles by Southern blotting analysis involving hybridization of PvuII-digested genomic fragments with a clone composed of the 51 nucleotide repeat sequence present in this gene, and detected two polymorphic systems in each individual. The distributions of allele sizes were the same in Japanese and Caucasians; the distribution within the first system ranged from 20 to 40 kb, and the other system showed variants 10-15 kb long (Fig.
Figure 1. Autoradiograph of Southern blots showing variations of MUC3 alleles in Japanese (a) and in Caucasians (b). Molecular weight markers are indicated immediately to the left of each figure. This is the first study to show an association between UC and a specific intestinal mucin gene, and there are two important features to our study. One is that the MUC3 gene lies in a chromosomal region of potential linkage with IBDs (6); two major intestinal mucins are known, MUC2 and MUC3, but no markers around the MUC2 gene have ever shown linkage to UC (6,17). The other feature is that we observed the association in different populations; ethnic difference is one of the characteristics of IBDs which makes it difficult to obtain consistent results in linkage analyses. Our findings suggest that the association between rare alleles of the MUC3 gene and UC may be common among races. A large portion of each mucin gene consists of tandem repeats which encode its protein backbone, and tandemly repeated sequences are prone to undergo deletions or insertions via unequal sister chromatid exchange or unequal crossover, becoming in the course of generations highly polymorphic VNTR loci containing more, or fewer, repeat units in a given allele than the ancestral sequence. For example, the human MUC1 gene contains from as few as 20 to as many as 125 tandem repeats in the population (18), and the MUC2 gene from 51 to 115 repeats (19). Table 1. Table 2. Human colonic mucin glycoproteins can be fractionated by ion-exchange chromatography into six species (I-VI). A selective reduction in species IV, one of the major mucin components, has been observed specifically in UC patients (7-9). That this abnormality is seen in monozygotic twins with UC as well as in their apparently healthy twin siblings clearly suggests a genetic basis for the observation (10). Furthermore, a comparable abnormality occurs in one of the best animal models of colitis, the cotton-top tamarin (Saguinus oedipus). When kept in captivity, this monkey develops a spontaneous chronic colitis that is histologically and clinically similar to human ulcerative colitis (20,21). The mechanism by which variation in the MUC3 VNTR might lead to a deficiency of mucin species IV is open to discussion. It is possible that variation in the length of the 51 bp repetitive region may itself influence mucin production or stability of the protein; in that scenario, substitutions or deletions caused by unequal sister chromatid exchange or unequal crossover might influence the quantity of functional mucin generated. However, a more plausible explanation is that rare alleles of the MUC3 gene may lead to qualitative abnormalities. Polymorphisms due to VNTRs in coding regions appear to alter protein configurations. For example, certain VNTR alleles of the dopamine D4 receptor affect the personality trait of novelty-seeking (22), and expansion of a VNTR within the androgen receptor results in spinal and bulbar atrophy (23). It is reasonable to suppose that the relative positions of the 18 bp interrupting sequences in the 51 bp repetitive region may affect the configuration of the mucin protein. A high-mannose oligosaccharide side chain of mucin is processed to a complex form in the Golgi apparatus, and whether a given oligosaccharide is processed or not is determined by the configuration of the protein, i.e. its accessibility to the processing enzymes (24). Thus, some variants of MUC3 glycoprotein might have difficulty in this process because of the alteration in the protein backbone structure, and that could explain not only the selective reduction in one mucin component but also the significant increase in mannose-rich glycoproteins of low molecular weight reported in UC patients (25). The immune system is thought to play a crucial role in the pathogenesis of IBDs as shown by the significantly high prevalence of antibodies to intestinal epithelial antigens both in patients with IBDs and in their relatives (26), and there are two possibilities with regard to our study. Carbohydrate side chains of mucin serve as specific binding sites for microorganisms, and competitively inhibit binding of bacteria to epithelial cells (27,28). Selective reduction of some mucin components may therefore impair mucosal defence against luminal bacteria which in turn may stimulate the auto-immune response to epithelial antigens (29,30). In spite of MUC3 expression throughout the gut, restriction of the inflammation to the large intestine in UC patients may be attributable to the 107-fold higher concentration of bacteria in the large intestine compared with the small intestine (31). The other possibility is that the immune response may be caused by the protein backbone of MUC3. The mannose-rich underglycosylated glycoprotein exposes the protein backbone, and this peptide can affect T cell function (32), or antibodies against the peptide may cross-react with intestinal epithelial antigen (33). Antibodies against the Gala(1,3)Gal epitope are reported to react with MUC1 peptide (34). In conclusion, our findings lend support to the hypothesis that mucin abnormality may be a significant factor in the pathogenesis of UC, and further suggest that altered MUC3 alleles may genetically predispose individuals to UC. In the Japanese population we studied 75 unrelated patients with UC and 168 unrelated controls, and to confirm the result we undertook two-stage examinations using Caucasian DNA samples obtained from 72 unrelated UC patients for the first examination, 85 for the second, and 171 healthy unrelated individuals. Japanese UC patients were ascertained through the First Department of Surgery, the University of Tokyo, or through the Second Department of Surgery, School of Medicine, Hamamatsu University, and for Japanese controls, patients who were operated on for breast cancer were used because of sample availability and no evidence of an altered risk of UC in patients with breast cancer. Caucasian patients were ascertained through the Gastroenterology Unit, Nuffield Department of Medicine, Radcliffe Infirmary. They were all British or North European Caucasian; Jewish patients were excluded because Jews have a greater prevalence of UC. Only British Caucasians were used for Caucasian controls, and they had neither a personal nor a family history of IBDs. One microgram of poly(A)+ RNA isolated from colon cancer cell line SW480 was reverse-transcribed using an oligo-dT15 primer and reverse transcriptase (Boehringer Mannheim, Mannheim, Germany). The cDNA product was amplified in a 25 µl reaction volume, using 25 pmol of each of the following primers that were synthesized by means of an Oligo 1000M DNA Synthesizer (Beckman, Fullerton, CA) on the basis of the 51 nucleotide tandem repeats reported previously (11): 5[prime]-TTTGATAACCACCTCTGAGAC-3[prime] (GSP1) and 5[prime]-GGAACATAGAAGAAGTGAAGC-3[prime] (GSP2). The PCR regime included one cycle of 94°C for 2 min, then 35 cycles of 94°C for 30 s, 55°C for 30 s, and 1 min at 72°C. This protocol was followed by an extension cycle of 5 min at 72°C. The PCR products were cloned into the vector pCR2.1 using the TA Cloning kit (Invitrogen, Carlsbad, CA) according to the manufacturers instructions. Clones containing MUC3 tandem repeats were detected by hybridization with the GSP3 primer (5[prime]-CACAGTACTCCCAGCTTCACTTCTTC-3[prime]) and sequenced with an ABI 377 Autosequencer (Perkin-Elmer, Foster City, CA). These plasmid clones served as probes for Southern blotting. Five micrograms of each genomic DNA was digested to completion with restriction enzyme PvuII (Toyobo, Tokyo, Japan) and the fragments were separated by electrophoresis in 0.5% agarose gels (20 × 25 cm) run at 40 V for 72 h, then denatured in 0.4 M NaOH for 20 min. DNAs were transferred to nylon membranes as described previously (35). Plasmid clones containing 51 bp tandem repeats were labelled by the random priming method with DNA polymerase I (Klenow; Toyobo) and [[alpha]-32P]dCTP (Amersham, Buckinghamshire, UK) for 3 h at 37°C, then hybridized to the membranes at 65°C overnight in a solution containing 7% polyethylene glycol 8000, 10% SDS and 200 µg/ml of salmon sperm DNA. The membranes were washed first in 2× SSC and then in a solution of 0.1% SSC and 0.1% SDS at 65°C, before exposure to Kodak X-OMAT AR film (Kodak, Rochester, NY). The frequencies of individuals carrying one or two rare VNTR alleles were compared in patients and controls using Fishers exact test. We examined both Japanese and Caucasian samples, and analysed the overall estimation by the Mantel-Haenszel statistical method after obtaining a non-significant homogeneity test. The association was considered statistically significant when the P-value was <0.05.
DISCUSSION
Japanese
Caucasian
Allele
(size in kb)Control (%)
n = 168UC (%)
n = 75Allele
(size in kb)Control (%)
n = 171UC (%)
1st n = 72
2nd n = 85
Total n = 157
a1 (18.00)
0 (0)
0 (0)
1 (0.6)
1 (0.3)
a2 (15.64)
0 (0)
1 (0.7)
0 (0)
1 (0.3)
A1 (14.94)
1 (0.3)
0 (0)
A2 (14.89)
1 (0.3)
0 (0)
A3 (14.73)
1 (0.3)
0 (0)
A4 (14.04)
1 (0.3)
2 (1.3)
A5 (13.69)
1 (0.3)
0 (0)
A6 (13.39)
0 (0)
1 (0.7)
A7 (13.33)
161 (47.9)
61 (40.7)
a3 (13.33)
31 (9.1)
7 (4.9)
11 (6.5)
18 (5.7)
A8 (13.28)
0 (0)
2 (1.3)
A9 (13.06)
2 (0.6)
1 (0.7)
A10 (12.96)
1 (0.3)
0 (0)
a4 (12.50)
0 (0)
1 (0.7)
0 (0)
1 (0.3)
a5 (12.04)
123 (36.0)
54 (37.5)
60 (35.3)
114 (36.3)
A11 (11.99)
3 (0.9)
2 (1.3)
A12 (11.71)
49 (14.6)
23 (15.3)
a6 (11.71)
132 (38.6)
51 (35.4)
71 (41.8)
122 (38.9)
A13 (11.46)
1 (0.3)
2 (1.3)
a7 (11.42)
6 (1.8)
4 (2.8)
6 (3.5)
10 (3.2)
a8 (11.18)
3 (0.9)
3 (2.1)
2 (1.2)
5 (1.6)
A14 (11.06)
113 (33.6)
53 (35.3)
a9 (11.06)
39 (11.4)
15 (10.4)
10 (5.9)
25 (8.0)
a10 (10.94)
5 (1.5)
5 (3.5)
8 (4.7)
13 (4.1)
A15 (10.70)
0 (0)
1 (0.7)
A16 (10.30)
1 (0.3)
1 (0.7)
A17 (10.11)
0 (0)
1 (0.7)
a11 (9.82)
0 (0)
2 (1.4)
0 (0)
2 (0.6)
a12 (9.48)
1 (0.3)
1 (0.7)
0 (0)
1 (0.3)
a13 (9.38)
2 (0.6)
0 (0)
1 (0.6)
1 (0.3)
Total
336
150
342
144
170
314
Population
Control (%)
UC (%)
Odds ratio (95% CI)
P-value
Japanese
11/168 (6.5)
12/75 (16.0)
2.72 (1.17-6.32)
0.0308
Caucasian
1st stage
17/72 (23.6)
2.80 (1.36-5.75)
0.0079
2nd stage
18/85 (21.2)
2.43 (1.20-4.92)
0.0196
Subtotal
17/171 (9.9)
35/157 (22.3)
2.60 (1.41-4.80)
0.0024
Combined (Mantel-Haenszel statistics)
2.64 (1.60-4.33)
0.0001
MATERIALS AND METHODS
Patients and controls
Reverse transcription and PCR amplification (RT-PCR)
Southern blotting analysis
Statistical analysis
REFERENCES
This article has been cited by other articles:
This page is run by Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, as part of the OUP Journals
Comments and feedback: www-admin{at}oup.co.uk
Last modification: 4 Feb 1999
Copyright©Oxford University Press, 1999.
![]()
CiteULike
Connotea
Del.icio.us What's this?
![]()
![]()

![]()
![]()
![]()
M. E. Homsi, R. Ducroc, J. Claustre, G. Jourdan, A. Gertler, M. Estienne, A. Bado, J.-Y. Scoazec, and P. Plaisancie
Leptin modulates the expression of secreted and membrane-associated mucins in colonic epithelial cells by targeting PKC, PI3K, and MAPK pathways
Am J Physiol Gastrointest Liver Physiol,
July 1, 2007;
293(1):
G365 - G373.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
R. J. Longman, R. Poulsom, A. P. Corfield, B. F. Warren, N. A. Wright, and M. G. Thomas
Alterations in the Composition of the Supramucosal Defense Barrier in Relation to Disease Severity of Ulcerative Colitis
J. Histochem. Cytochem.,
December 1, 2006;
54(12):
1335 - 1348.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
M. C. Rose and J. A. Voynow
Respiratory Tract Mucin Genes and Mucin Glycoproteins in Health and Disease
Physiol Rev,
January 1, 2006;
86(1):
245 - 278.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
H. S. Silverman, M. Sutton-Smith, K. McDermott, P. Heal, S.-H. Leir, H. R. Morris, M. A. Hollingsworth, A. Dell, and A. Harris
The contribution of tandem repeat number to the O-glycosylation of mucins
Glycobiology,
April 1, 2003;
13(4):
265 - 277.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
G. D. Leikauf, M. T. Borchers, D. R. Prows, and L. G. Simpson
Mucin Apoprotein Expression in COPD*
Chest,
May 1, 2002;
121
(2009):
166S - 182S.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
A P CORFIELD, N MYERSCOUGH, R LONGMAN, P SYLVESTER, S ARUL, and M PIGNATELLI
Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease
Gut,
October 1, 2000;
47(4):
589 - 594.
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
T. Shirazi, R. J Longman, A. P Corfield, and C. S J Probert
Mucins and inflammatory bowel disease
Postgrad. Med. J.,
August 1, 2000;
76(898):
473 - 478.
[Abstract]
[Full Text]
![]()
This Article ![]()
![]()
Abstract
![]()
FREE Full Text (PDF)
![]()
Alert me when this article is cited
![]()
Alert me if a correction is posted
![]()
Services ![]()
![]()
Email this article to a friend
![]()
Similar articles in this journal
![]()
Similar articles in ISI Web of Science
![]()
Similar articles in PubMed
![]()
Alert me to new issues of the journal
![]()
Add to My Personal Archive
![]()
Download to citation manager
![]()
Search for citing articles in:
ISI Web of Science (46)
![]()
Request Permissions ![]()
Google Scholar ![]()
![]()
Articles by Kyo, K.
![]()
Articles by Nakamura, Y.
![]()
Search for Related Content
![]()
PubMed ![]()
![]()
PubMed Citation
![]()
Articles by Kyo, K.
![]()
Articles by Nakamura, Y.
![]()
Social Bookmarking ![]()
![]()
What's this?